METROPOLIS.NS Overview

Company Profile

Related stocks

SYNGENE.NS • India

SYNGENE INTERNATIONAL LTD

347.4 INR

1.44B USD 1Y -45.1%

VIJAYA.NS • India

VIJAYA DIAGNOSTIC CEN LTD

1,436.6 INR

1.53B USD 1Y +44.5%

THYROCARE.BO • India

Thyrocare Technologies Limited

499 INR

820.66M USD 1Y +22%

SAILIFE.NS • India

SAI LIFE SCIENCES LIMITED

1,487.9 INR

3.27B USD 1Y +74.7%

LALPATHLAB.NS • India

DR. LAL PATH LABS LTD.

1,933.6 INR

3.34B USD 1Y +23.3%

4544.T • Japan

H.U. GROUP HLDGS INC

3,580 JPY

1.23B USD 1Y -4%

300406.SZ • China

BSBE

12.14 CNY

1.06B USD 1Y -9.7%

300685.SZ • China

AMOYDX

20.3 CNY

1.18B USD 1Y -11.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Diagnostics & Research

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

33.4% p.a.

Max Drawdown (5Y)

-65.5%

Sharpe Ratio (5Y)

-0.25

Beta Factor

0.20

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 54.5 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -65.5% in the extended horizon.